Literature DB >> 26861953

Pharmacotherapy of ADHD in Slovenia: realities and perspectives.

Matej Stuhec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26861953     DOI： 10.1007/s00787-015-0811-4

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  9 in total

Review 1.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 2.  Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.

Authors:  Matej Stuhec; Barbara Munda; Vesna Svab; Igor Locatelli
Journal:  J Affect Disord       Date:  2015-03-13       Impact factor: 4.839

3.  Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.

Authors:  Amaia Hervas; Michael Huss; Mats Johnson; Fiona McNicholas; Judy van Stralen; Sasha Sreckovic; Andrew Lyne; Ralph Bloomfield; Vanja Sikirica; Brigitte Robertson
Journal:  Eur Neuropsychopharmacol       Date:  2014-10-23       Impact factor: 4.600

Review 4.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

5.  Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.

Authors:  Matej Štuhec; Igor Locatelli; Vesna Švab
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-03-24       Impact factor: 2.576

6.  The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Authors:  Ingrid Schubert; Ingrid Köster; Gerd Lehmkuhl
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

7.  Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.

Authors:  Blanca Bolea-Alamañac; David J Nutt; Marios Adamou; Phillip Asherson; Stephen Bazire; David Coghill; David Heal; Ulrich Müller; John Nash; Paramala Santosh; Kapil Sayal; Edmund Sonuga-Barke; Susan J Young
Journal:  J Psychopharmacol       Date:  2014-02-12       Impact factor: 4.153

Review 8.  Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.

Authors:  N S Roskell; J Setyawan; E A Zimovetz; P Hodgkins
Journal:  Curr Med Res Opin       Date:  2014-04-15       Impact factor: 2.580

9.  Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective.

Authors:  Matej Štuhec; Vesna Švab; Igor Locatelli
Journal:  Croat Med J       Date:  2015-04       Impact factor: 1.351
  9 in total
  1 in total

1.  Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study.

Authors:  Matej Stuhec; Igor Locatelli
Journal:  Int J Clin Pharm       Date:  2018-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.